Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Informatics
Genentech and Nividia form AI computing pact
by Michael McCoy
November 23, 2023
| A version of this story appeared in
Volume 101, Issue 39
Roche’s Genentech unit and the semiconductor designer Nvidia have formed a research collaboration combining Genentech’s artificial intelligence capabilities with Nvidia’s computing expertise. Under the pact, Genentech will house its algorithms on Nvidia’s cloud platform with the goal of accelerating drug discovery. Nividia, which has become one of the world’s most valuable companies by stock market value, has invested in AI-driven biotechnology firms, including Recursion Pharmaceuticals and Terray Therapeutics.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X